Sanofi, 10% Owner at REGENERON PHARMACEUTICALS INC (REGN), bought 105,820 shares at $478.12 ($51.0M) on 2017-08-24, disclosed to the SEC on 2017-08-25.
Open-market purchase of $51.0M REGN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $474.86 | 2,633 | $1.3M | 2.5% |
| 2 | $475.93 | 5,103 | $2.4M | 4.8% |
| 3 | $477.42 | 10,929 | $5.2M | 10.2% |
| 4 | $478.12 | 3,326 | $1.6M | 3.1% |
| 5 | $479.23 | 8,273 | $4.0M | 7.8% |
| 6 | $480.36 | 13,638 |
| $6.6M |
| 12.8% |
| 7 | $481.33 | 17,756 | $8.5M | 16.8% |
| 8 | $481.96 | 1,700 | $819K | 1.6% |
| 9 | $483.31 | 5,016 | $2.4M | 4.8% |
| 10 | $484.27 | 8,982 | $4.3M | 8.5% |
| 11 | $485.55 | 5,724 | $2.8M | 5.4% |
| 12 | $486.63 | 6,920 | $3.4M | 6.6% |
| 13 | $487.55 | 8,860 | $4.3M | 8.5% |
| 14 | $488.57 | 6,960 | $3.4M | 6.7% |
| Total | $482.04 avg | 105,820 | $51.0M | 100% |
| Filing → |
| ICVX | BUY | 2021-08-02 | $1.0M | — | Filing → |
| INZY | BUY | 2020-07-29 | $1.3M | — | Filing → |
| REGN | SELL | 2020-06-11 | $143.7M | — | Filing → |